Home Cart 0 Sign in  

[ CAS No. 3401-36-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 3401-36-3
Chemical Structure| 3401-36-3
Structure of 3401-36-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 3401-36-3 ]

Related Doc. of [ 3401-36-3 ]

Alternatived Products of [ 3401-36-3 ]

Product Details of [ 3401-36-3 ]

CAS No. :3401-36-3 MDL No. :MFCD00053548
Formula : C15H16N2O6 Boiling Point : -
Linear Structure Formula :- InChI Key :OFIYNISEFIEQBC-JTQLQIEISA-N
M.W : 320.30 Pubchem ID :837751
Synonyms :
Chemical Name :2,5-Dioxopyrrolidin-1-yl ((benzyloxy)carbonyl)-L-alaninate

Calculated chemistry of [ 3401-36-3 ]

Physicochemical Properties

Num. heavy atoms : 23
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 8
Num. H-bond acceptors : 6.0
Num. H-bond donors : 1.0
Molar Refractivity : 80.72
TPSA : 102.01 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.64 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.83
Log Po/w (XLOGP3) : 0.87
Log Po/w (WLOGP) : 0.38
Log Po/w (MLOGP) : 0.89
Log Po/w (SILICOS-IT) : 0.69
Consensus Log Po/w : 0.93

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.04
Solubility : 2.93 mg/ml ; 0.00914 mol/l
Class : Soluble
Log S (Ali) : -2.6
Solubility : 0.812 mg/ml ; 0.00253 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.87
Solubility : 0.432 mg/ml ; 0.00135 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.53

Safety of [ 3401-36-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 3401-36-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 3401-36-3 ]
  • Downstream synthetic route of [ 3401-36-3 ]

[ 3401-36-3 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 6066-82-6 ]
  • [ 1142-20-7 ]
  • [ 3401-36-3 ]
Reference: [1] Polish Journal of Chemistry, 2005, vol. 79, # 12, p. 1909 - 1917
[2] Journal of the Chemical Society - Perkin Transactions 1, 1998, # 15, p. 2443 - 2449
[3] Liebigs Annales, 1996, # 3, p. 335 - 348
[4] Journal of Pharmaceutical Sciences, 1993, vol. 82, # 1, p. 1 - 10
[5] Chemische Berichte, 1980, vol. 113, # 11, p. 3511 - 3516
[6] Dalton Transactions, 2006, # 1, p. 137 - 148
[7] Chemistry Letters, 1985, p. 123 - 126
[8] Bulletin of the Chemical Society of Japan, 1987, vol. 60, # 7, p. 2409 - 2418
[9] Journal of Pharmaceutical Sciences, 1994, vol. 83, # 7, p. 989 - 998
[10] Journal of Medicinal Chemistry, 1994, vol. 37, # 18, p. 2841 - 2845
[11] Bioorganic & Medicinal Chemistry Letters, 1998, vol. 8, # 23, p. 3343 - 3346
[12] Chemistry - A European Journal, 2004, vol. 10, # 16, p. 3879 - 3890
[13] Tetrahedron Letters, 2008, vol. 49, # 48, p. 6885 - 6888
[14] Biochimie, 2013, vol. 95, # 6, p. 1120 - 1126
[15] Tetrahedron, 2013, vol. 69, # 2, p. 551 - 558
[16] Chemistry - A European Journal, 2013, vol. 19, # 48, p. 16256 - 16262
[17] Organic Preparations and Procedures International, 2014, vol. 46, # 4, p. 370 - 375
[18] Organic and Biomolecular Chemistry, 2016, vol. 14, # 47, p. 11125 - 11136
  • 2
  • [ 1142-20-7 ]
  • [ 3401-36-3 ]
Reference: [1] Tetrahedron Letters, 2002, vol. 43, # 9, p. 1661 - 1664
  • 3
  • [ 1142-20-7 ]
  • [ 90704-86-2 ]
  • [ 3401-36-3 ]
Reference: [1] Bulletin of the Academy of Sciences of the USSR, Division of Chemical Science (English Translation), 1984, vol. 33, p. 1067 - 1070[2] Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1984, # 5, p. 1163 - 1165
  • 4
  • [ 1142-20-7 ]
  • [ 3401-36-3 ]
Reference: [1] Journal of Organic Chemistry, 1987, vol. 52, # 12, p. 2364 - 2367
  • 5
  • [ 1142-20-7 ]
  • [ 75513-55-2 ]
  • [ 3401-36-3 ]
Reference: [1] Tetrahedron Letters, 1980, vol. 21, # 15, p. 1467 - 1468
  • 6
  • [ 501-53-1 ]
  • [ 3401-36-3 ]
Reference: [1] Bulletin of the Chemical Society of Japan, 1987, vol. 60, # 7, p. 2409 - 2418
  • 7
  • [ 1142-20-7 ]
  • [ 57296-03-4 ]
  • [ 3401-36-3 ]
Reference: [1] Tetrahedron Letters, 1983, vol. 24, # 41, p. 4451 - 4454
  • 8
  • [ 74124-79-1 ]
  • [ 1142-20-7 ]
  • [ 3401-36-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 20, p. 5559 - 5562
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 3401-36-3 ]

Amino Acid Derivatives

Chemical Structure| 3496-11-5

[ 3496-11-5 ]

(S)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate

Similarity: 0.98

Chemical Structure| 4467-55-4

[ 4467-55-4 ]

(R)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-3-methylbutanoate

Similarity: 0.98

Chemical Structure| 65581-25-1

[ 65581-25-1 ]

(R)-2,5-Dioxopyrrolidin-1-yl 2-(((benzyloxy)carbonyl)amino)-4-methylpentanoate

Similarity: 0.96

Chemical Structure| 3397-35-1

[ 3397-35-1 ]

Z-Leu-Osu

Similarity: 0.96

Chemical Structure| 34404-36-9

[ 34404-36-9 ]

Boc-Lys(Z)-OSu

Similarity: 0.94